✦ LIBER ✦

A retrospective study of the time to clinical endpoints for advanced prostate cancer

✍ Scribed by Nima Sharifi; William L. Dahut; Seth M. Steinberg; William D. Figg; Christopher Tarassoff; Philip Arlen; James L. Gulley

Book ID: 109052054
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 156 KB
Volume: 96
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2005.05798.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy for advanced prostate cance

Chemotherapy for advanced prostate cancer: Results of new clinical trials and future studies

✍ Andrew J. Armstrong; Michael A. Carducci 📂 Article 📅 2005 🏛 Current Science Inc. 🌐 English ⚖ 603 KB

Efficacy of primary hormonal therapy for

Efficacy of primary hormonal therapy for patients with localized and locally advanced prostate cancer: A retrospective multicenter study

✍ SATORU UENO; MIKIO NAMIKI; TAKASHI FUKAGAI; HIDETOSHI EHARA; MICHIYUKI USAMI; HI 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB

Clinical staging system for cancer of th

Clinical staging system for cancer of the salivary gland: A retrospective study

✍ Seymour H. Levitt; Richard B. McHugh; Orlando Gómez-marin; Vincent J. Hyams; Edw 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 1023 KB

Feasibility of antegrade radical prostat

Feasibility of antegrade radical prostatectomy for clinically locally advanced prostate cancer: a comparative study with clinically localized disease

✍ Shinya Yamamoto; Satoru Kawakami; Junji Yonese; Yasuhisa Fujii; Tetsuro Tsukamot 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Editorial Comment to Feasibility of ante

Editorial Comment to Feasibility of antegrade radical prostatectomy for clinically locally advanced prostate cancer: A comparative study with clinically localized disease

✍ Shigeto Ishidoya 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Localized prostate cancer. Relationship

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

✍ Thomas A. Stamey; Fuad S. Freiha; John E. McNeal; Elise A. Redwine; Alice S. Whi 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

Background. Using the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute and American total mortality rates, the authors calculated the probability at birth of having a diagnosis of prostate cancer within a man's life to be 8.8% and then subtracted the incidence of